Efficacy News and Research

RSS
Zero benefit of Hydroxychloroquine or Chloroquine in COVID-19, says extensive study

Zero benefit of Hydroxychloroquine or Chloroquine in COVID-19, says extensive study

The infection of lung stem cells may determine SARS-CoV-2 pathogenicity

The infection of lung stem cells may determine SARS-CoV-2 pathogenicity

Can Chlorpromazine help treat COVID-19?

Can Chlorpromazine help treat COVID-19?

Capillary leakage important in COVID-19 respiratory distress

Capillary leakage important in COVID-19 respiratory distress

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients

Supportive care for reducing fatigue may not be sufficiently adhered to by breast cancer patients

Supportive care for reducing fatigue may not be sufficiently adhered to by breast cancer patients

Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast cancer

Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast cancer

Breast cancer survivors underutilize supportive care to relieve cancer-related fatigue

Breast cancer survivors underutilize supportive care to relieve cancer-related fatigue

Despite low stroke rates among COVID-19 patients, cases are still more severe

Despite low stroke rates among COVID-19 patients, cases are still more severe

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

GlobalData: Patients treated for ICU delirium will increase as COVID-19 outbreak continues

Scientists identify compounds in noxious weed that reduce virulence of Staphylococcus bacteria

Scientists identify compounds in noxious weed that reduce virulence of Staphylococcus bacteria

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

Study evaluates the effectiveness of interferon beta 1b in COVID-19 pneumonia

Santen’s VEKTIS study demonstrates efficacy and tolerability of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivis, over 12 months

Santen’s VEKTIS study demonstrates efficacy and tolerability of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivis, over 12 months

Excessive blood clotting and stroke in COVID-19 patients

Excessive blood clotting and stroke in COVID-19 patients

Comprehensive review of clioquinol drug gives valuable insights

Comprehensive review of clioquinol drug gives valuable insights

Analysis: Get ready for the vaccine — they’re never simple

Analysis: Get ready for the vaccine — they’re never simple

Lattice light-sheet microscopy could help in drug and vaccine development

Lattice light-sheet microscopy could help in drug and vaccine development

New strategy promotes healthy lifestyle behaviors in obese, overweight women

New strategy promotes healthy lifestyle behaviors in obese, overweight women

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

Durvalumab plus chemotherapy improved overall survival rate for mesothelioma patients

FDA approves IND application by Octapharma USA for severe COVID-19 patients

FDA approves IND application by Octapharma USA for severe COVID-19 patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.